ABACAVIR (ABACAVIR SULFATE); LAMIVUDINE

USDailyMed:Trizivir AU:B3 J05AR04(WHO) AU:S4(Prescription only)CA:Schedule IVUK:POM(Prescription only)US:℞-onlyEU:Rx-onlyIn general: ℞ (Prescription only) 136470-78-5N 468908 21106400Y D10838N 058986 Abacavir/lamivudine/zidovudine, sold under the brand nameTrizivir, is afixed-dose combinationantiretroviral medicationfor the treatment ofHIV/AIDS.It contains threereverse transcriptase inhibitorspatented byGlaxoSmithKlineand marketed by a joint venture withPfizer,ViiV Healthcare: abacavir sulfate(ABC)lamivudine(3TC)zidovudine(AZTorZDV) It is indicated in the treatment ofAIDS/HIV-1.For this purpose, the combination is very useful inpregnantwomen to decrease the risk ofmother-to-child transmission. The most common effects include headache and nausea (feeling sick). Abacavir/lamivudine/zidovudine was approved for use in the United States and the European Union in 2000.In December 2013,Lupin Limitedlaunched a generic version of abacavir/lamivudine/zidovudine.